US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Citius Pharmaceuticals Reports Positive Early Stage Results of Cancer Combo Treatment

Seeking AlphaNov 11 10:47 ET

Express News | Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (Keytruda®) and Lymphir™ in Cancer Patients With Recurrent Solid Tumors

ReutersNov 11 08:45 ET

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA) and LYMPHIR in Cancer Patients With Recurrent Solid Tumors

PR NewswireNov 11 08:45 ET

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaOct 21 16:31 ET

Dr. Reddy's Laboratories Agreed To Partially Defer A Milestone Payment From Citius Oncology, Inc., Due On September 9, 2024, Upon FDA Approval Of LYMPHIR, Without Penalty, Pending Further Discussions, As Per Their 2021 Asset Purchase Agreement

BenzingaSep 13 08:40 ET